749

Recombinant SARS-CoV-2 Spike RBD Protein, His tag (Animal-Free) | PRP2039

(No reviews yet) Write a Review
SKU:
749-PRP2039
Availability:
Usually ships in 5 working days
NULL173.00 - NULL6,264.00

Description

Recombinant SARS-CoV-2 Spike RBD Protein, His tag (Animal-Free) | PRP2039 | Gentaur UK, US & Europe Distribution

Product Category: Cytology

Application: Cytokines

Product Type: Cytokines (Animal-Free)

Sequence: Amino acid sequence derived from SARS-CoV-2 (COVID-19) Spike RBD protein (YP_009724390.1, Arg 319 - Phe 541) was expressed with a polyhistidine tag at the C-terminus.

Activity: N/A

protein Lenght: The recombinant SARS-CoV-2 (COVID-19) Spike RBD protein consists of 229 amino acids and predicts a molecular mass of 26.5 kD.The apparent molecular mass of the human CD33 is approximately 32-35 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Preparation: HEK 293 Cells

Purity: >95% as determined by SDS-PAGE

Formulation: Lyophilized from sterile PBS, pH 7.4.

Kit Component: N/A

Features & Benefits : Endotoxin: < 1 EU per µg of the protein as determined by the LAL method.

Molecular Weight: 26.5kDa

Usage Note: Always centrifuge tubes before opening. It is recommended to reconstitute the lyophilized SARS-CoV-2 (COVID-19) S protein RBD protein not less than 100 µg/mL, which can then be further diluted to other aqueous solutions.

Storage Conditions: Lyophilized Recombinant SARS-CoV-2 Spike RBD Protein, His tag (Animal-Free) should be stored desiccated below -20°C. Upon reconstitution, the protein should be stored at 4°C between 2-7 days and for future use below -20°C. For long term storage it is recommended to add a carrier protein (0.121% HSA or BSA) . Please prevent freeze-thaw cycles.

Shipping: The product is shipped at ambient temperature.

Background: COVID-19 has become pandemic with higher morbidity and mortality rates after its start from Wuhan city of China. The infection by RNA virus, also known as SARS-CoV-2 or 2019-nCoV, from β class of corona viruses has been found to be responsible for COVID-19. Structural analysis and evidences have been indicated that interaction between a segment of receptor binding domain (RBD) from S protein of virus and human angiotensin-converting enzyme 2 (hACE2) is essential for cellular entry of virus. Inhibition of RBD-hACE2 interaction by different molecular scaffolds can be used as a preferred strategy for control of SARS-CoV-2 infection.

Alternative Names: SARS-CoV-2-Spike-RBD,RBD,SARS-CoV-2 Spike RBD,SARS-CoV-2 SP RBD,2019-nCoV SARS-CoV-2 Spike Protein (RBD)

Search Names: SARS-CoV-2-Spike-RBD,RBD,SARS-CoV-2 Spike RBD,SARS-CoV-2 SP RBD,2019-nCoV SARS-CoV-2 Spike Protein (RBD)

Tag: SARS-CoV-2 Spike RBD

View AllClose